Related Experiment Videos
CD36 and atherosclerosis
1Weill Medical College of Cornell University, Department of Medicine, New York, New York 10021, USA.
Insights
Cluster of Differentiation 36 (CD36) plays a key role in various cellular processes and diseases. Recent genetic advancements highlight its in-vivo relevance, paving the way for targeted therapies.
Area of Science:
- Molecular Biology
- Immunology
- Cardiovascular Research
Background:
- Cluster of Differentiation 36 (CD36) is a scavenger receptor involved in lipid metabolism and cellular adhesion.
- Its roles span normal physiological processes and various pathological conditions, including atherosclerosis and diabetes.
- Despite being identified over 25 years ago, its in-vivo significance is only recently being elucidated through advanced genetic technologies.
Purpose of the Study:
- To review the diverse functions of CD36 in both normal and pathological contexts.
- To emphasize the growing in-vivo evidence supporting the physiological and pathological relevance of CD36.
- To highlight the potential for developing targeted therapeutics based on CD36 signaling mechanisms.
Main Methods:
- Review of existing literature and recent genetic studies.
- Analysis of in-vivo evidence for CD36's roles.
- Exploration of CD36 signaling pathways.
Main Results:
- CD36 mediates critical functions such as apoptotic cell uptake, lipid metabolism, and inflammation modulation.
- In-vivo studies increasingly confirm CD36's involvement in diseases like atherosclerosis, diabetes, and cardiomyopathy.
- Emerging evidence points to CD36's role in angiogenesis and transforming growth factor-beta activation.
Conclusions:
- CD36 is a multifunctional protein with significant implications in human health and disease.
- Advancements in genetic technology are crucial for understanding CD36's in-vivo functions.
- Further research into CD36 signaling mechanisms will enable the development of novel therapeutic strategies.
Abstract:
CD36 has been associated with diverse normal and pathologic processes. These include scavenger receptor functions (uptake of apoptotic cells and modified lipid), lipid metabolism and fatty acid transport, adhesion, angiogenesis, modulation of inflammation, transforming growth factor-beta activation, atherosclerosis, diabetes and cardiomyopathy. Although CD36 was identified more than 25 years ago, it is only with the advent of recent genetic technology that in-vivo evidence has emerged for its physiologic and pathologic relevance. As these in-vivo studies are expanded, we will gain further insight into the mechanism(s) by which CD36 transmits a cellular signal, and this will allow the design of specific therapeutics that impact on a particular function of CD36.